arabinofuranosyluracil has been researched along with Neoplasms in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (16.67) | 18.7374 |
1990's | 2 (11.11) | 18.2507 |
2000's | 9 (50.00) | 29.6817 |
2010's | 4 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alauddin, MM | 1 |
Douglas, KA; Kim, S; Lawhorn-Crews, JM; Li, J; LoRusso, PM; Mangner, TJ; McHugh, CI; Shields, AF; Wu, J | 1 |
Collins, JM; Douglas, KA; Jones, SK; Lawhorn-Crews, JM; Mangner, TJ; McHugh, CI; Modi, D; Shields, AF | 1 |
Chen, Q; Deng, X; He, F; Huang, Y; Li, GC; Ling, CC; Liu, Y; Minami, A; Sun, X; Wen, B; Xing, L; Zanzonico, PB | 1 |
Emerick, LE; Krohn, KA; Plotnik, DA; Schwartz, JL; Unadkat, JD | 1 |
Grierson, JR; Jordan, R; Krohn, KA; Schwartz, JL; Tamura, Y | 1 |
Collins, JM; Douglas, K; Mangner, TJ; Muzik, O; Shields, AF; Sloan, A; Sun, H; Vaishampayan, U | 1 |
Deng, WP; Gelovani, JG; Hwang, JJ; Lin, M; Liu, RS; Wang, HE; Wei, HJ; Yu, HM | 1 |
Douglas, KA; Lawhorn-Crews, JM; Shields, AF; Tehrani, OS | 1 |
Knaus, EE; Lee, YW; Mercer, JR; Wiebe, LI | 1 |
Kato, A; Ogura, K; Okuda, H; Takubo, H; Watabe, T | 1 |
Collins, JM; Katki, AG; Klecker, RW | 1 |
Cheng, YC | 1 |
Akhurst, T; Balatoni, J; Bennett, JJ; Blasberg, R; Doubrovin, M; Federoff, H; Finn, R; Fong, Y; Hackman, T; Johnson, P; Larson, SM; Malholtra, S; Tjuvajev, J | 1 |
Bermudes, D; Blasberg, R; King, I; Luo, X; Tjuvajev, J; Zheng, LM | 1 |
Hill, DL; Nan, L; Oliver, P; Rhie, JK; Wang, H; Wang, S; Wang, Z; Zhang, R | 1 |
Abbruzzese, JL; Castellanos, AM; Krakoff, IH; Legha, SS; Levy, JK; Raber, MN; Schmidt, S | 1 |
Burchenal, JH; Fanucchi, MP; Fox, JJ; Leyland-Jones, B; Watanabe, KA; Young, CW | 1 |
1 review(s) available for arabinofuranosyluracil and Neoplasms
Article | Year |
---|---|
Journey of 2'-deoxy-2'-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU): from Antiviral Drug to PET Imaging Agent.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Carbon Radioisotopes; Contrast Media; Fluorine Radioisotopes; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
2 trial(s) available for arabinofuranosyluracil and Neoplasms
Article | Year |
---|---|
Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase.
Topics: Arabinofuranosyluracil; Humans; Infusions, Intravenous; Neoplasms; Positron-Emission Tomography; Prodrugs; Thymidylate Synthase | 2016 |
Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer.
Topics: Adult; Aged; Arabinofuranosyluracil; Biomarkers, Tumor; DNA, Neoplasm; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2005 |
15 other study(ies) available for arabinofuranosyluracil and Neoplasms
Article | Year |
---|---|
Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents:
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Capecitabine; Dideoxynucleosides; Female; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers.
Topics: Animals; Antigens, Neoplasm; Arabinofuranosyluracil; Autoradiography; Biomarkers; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxia; Etanidazole; Female; Gene Expression; Green Fluorescent Proteins; Herpesvirus 1, Human; HT29 Cells; Humans; Hydrocarbons, Fluorinated; Immunohistochemistry; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms; Nitroimidazoles; Positron-Emission Tomography; Thymidine Kinase; Tissue Distribution; Transplantation, Heterologous | 2008 |
Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells.
Topics: Arabinofuranosyluracil; Biological Transport; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Equilibrative Nucleoside Transport Proteins; Humans; Kinetics; Neoplasms; Positron-Emission Tomography; Thymidine; Tritium | 2010 |
Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.
Topics: Animals; Arabinofuranosyluracil; Cell Division; Cell Line, Tumor; Dideoxynucleosides; DNA; Drug Delivery Systems; Humans; Metabolic Clearance Rate; Mice; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Thymidine; Thymidine Kinase; Tomography, Emission-Computed; Tritium | 2003 |
Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cell Line, Tumor; Female; Floxuridine; Fluorodeoxyglucose F18; Ganciclovir; Genetic Therapy; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; Mice; Neoplasms; Prodrugs; Thymidine Kinase; Tyrosine | 2006 |
Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2.
Topics: Arabinofuranosyluracil; Cell Line, Tumor; Humans; Mitochondria; Neoplasms; Oxidative Stress; Radionuclide Imaging; Radiopharmaceuticals; Thymidine Kinase; Tritium | 2008 |
The synthesis of [36Cl]-, [82Br]- and [123I]-labelled 1-(3'-chloro-(bromo and iodo)-3'-deoxy-beta-D-arabinofuranosyl)uracil.
Topics: Arabinofuranosyluracil; Bromine; Chlorine; Humans; Iodine Radioisotopes; Isotope Labeling; Neoplasms; Radioisotopes; Radionuclide Imaging; Uridine | 1984 |
A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
Topics: Animals; Antimetabolites, Antineoplastic; Antiviral Agents; Arabinofuranosyluracil; Bromouracil; Cause of Death; Dihydrouracil Dehydrogenase (NADP); Drug Interactions; Fluorouracil; Half-Life; Herpes Zoster; Humans; Liver; Neoplasms; Oxidoreductases; Prodrugs; Rats; Tissue Distribution | 1998 |
Suicide prodrugs activated by thymidylate synthase: rationale for treatment and noninvasive imaging of tumors with deoxyuridine analogues.
Topics: Animals; Arabinofuranosyluracil; Cell Division; DNA; Floxuridine; Fluorine Radioisotopes; Humans; Methylation; Mice; Neoplasms; Phosphorylation; Prodrugs; Thymidylate Synthase; Tumor Cells, Cultured | 1999 |
Potential use of antiviral L(-)nucleoside analogues for the prevention or treatment of viral associated cancers.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Dioxolanes; Hepatitis B virus; Herpesvirus 4, Human; Humans; Neoplasms; Nucleosides; Stereoisomerism; Structure-Activity Relationship; Uracil; Virus Diseases; Zalcitabine | 2001 |
Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer.
Topics: Antiviral Agents; Arabinofuranosyluracil; Autoradiography; Biological Therapy; Herpesvirus 1, Human; Humans; Neoplasms; Promoter Regions, Genetic; Thymidine Kinase; Tomography, Emission-Computed; Tumor Cells, Cultured; Virus Replication | 2001 |
Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET) for diagnostic imaging.
Topics: Animals; Arabinofuranosyluracil; Genetic Markers; Genetic Vectors; Herpesvirus 1, Human; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms; Protein-Tyrosine Kinases; Salmonella; Tissue Distribution; Tumor Cells, Cultured | 2001 |
Radiolabeled 2'-fluorodeoxyuracil-beta-D-arabinofuranoside (FAU) and 2'-fluoro-5-methyldeoxyuracil-beta -D-arabinofuranoside (FMAU) as tumor-imaging agents in mice.
Topics: Animals; Arabinofuranosyluracil; DNA, Neoplasm; Humans; Mice; Mice, SCID; Muscle, Skeletal; Neoplasm Transplantation; Neoplasms; Radiopharmaceuticals; Spleen; Thymidine; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous | 2002 |
Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity.
Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Colonic Neoplasms; Drug Evaluation; Electroencephalography; Female; Fibrosarcoma; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Nervous System Diseases; Nervous System Neoplasms | 1989 |
Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU).
Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Central Nervous System Diseases; Drug Evaluation; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Platelet Count; Uridine; Vomiting | 1985 |